<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20221213056809N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2023-01-24</date_registration>
      <primary_sponsor>Islamic Azad University</primary_sponsor>
      <public_title>The effect of eight weeks of progressive aerobic activity with consumption of green tea and green coffee on fat oxidation and blood pressure in overweight girls</public_title>
      <acronym></acronym>
      <scientific_title>The effect of eight weeks of progressive aerobic activity with consumption of green tea and green coffee on fat oxidation and blood pressure in overweight girls</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2022-09-26</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>48</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/67992</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Triple blinded, Placebo: Used, Assignment: Other, Purpose: Health service research, Randomization description: The subjects were examined in four groups by a simple random selection method. In relation to randomization, the names of 48 subjects are written on special cards and placed in a bag, and the cards are selected one after the other. After choosing each card from the bag, the card was placed in the bag again, Blinding description: The herbal supplement was distributed to the intervention group and the placebo to the control group by the laboratory officials based on the randomization results announced by the laboratory supervisor, and the researchers did not know the results of the randomization and the type of package they delivered to the subjects. The researcher only had to provide the supplement necessary for the intervention and deliver it to the laboratory supervisor.</study_design>
      <phase>3</phase>
      <hc_freetext>overweight girls.</hc_freetext>
      <i_freetext>Intervention group: green coffee and green tea approved by the Food and Drug Organization will be purchased from a reputable store with a special grinder, the experimental groups will receive the amount of green coffee equal to 3 mg per kilogram of body weight and the amount of green tea equal to 3 mg per kilogram of body weight. The body will receive 250 ml of boiling water in separate containers every day 20 minutes before breakfast and 20 minutes before lunch at the same time. After finishing the last session in all groups, the second blood sampling was done before breakfast. Also, the physical and physiological indicators of the subjects will be measured. To implement the progressive aerobic exercise program, the subjects of the experimental and control groups in an eight-week aerobic exercise program, three sessions a week, each session 60 minutes with an intensity of 65 to 85% of the maximum heart rate according to table (1) after measurement Anthropometric characteristics will be included. The program of one session included 10 minutes of warm-up, 30 minutes of aerobic exercise (aerobic) running and local movements, and 5 minutes of cooling down, which started with an intensity of 65% of the maximum heart rate and 5% every two weeks. In the last week, reach 85% of the maximum heart rate.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
It is possible to share data such as information about the main outcome or the like.

When:
The access period starts 6 months after the results are published

To whom:
It will be available only to researchers working in academic and scientific institutions

Conditions:
There are no other conditions

Where to obtain:
Nasrin Babaei 1, Tooraj Mohammad Zamani2, Vahid Kazemizadeh3

1- Department of Physical Education and Sports Sciences, Islamabad Gharb Branch, Islamic Azad University, Islamabad Gharb, Iran.
2- Department of Physical Education and Sports Sciences, Islamabad Gharb Branch, Islamic Azad University, Islamabad Gharb, Iran.
3- Department of Exercise Physiology, Faculty of Sports Sciences, Razi University, Kermanshah, Iran.

How to obtain:
The access period starts 6 months after the results are published

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Tooraj Mohammad Zamani</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Kermanshah Province, Eslamabad-e-Gharb, Asian Highway</address>
        <city>Islamabad Gharb</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>۶۷۶۱۷۸۳۱۴۶</zip>
        <telephone>+98 83 2532 3530</telephone>
        <email>toorag.zamani@gmail.com</email>
        <affiliation>Islamic Azad University</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Nasrin Babaei</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Kermanshah Province, Eslamabad-e-Gharb, Asian Highway</address>
        <city>Islamabad Gharb</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>۶۷۶۱۷۸۳۱۴۶</zip>
        <telephone>+98 83 4532 3533</telephone>
        <email>vahid13k17@gmail.com</email>
        <affiliation>Islamic Azad University</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>. None of the subjects had a history of chronic diseases such as cardiovascular diseases, diabetes, various cancers, kidney and digestive disorders, or any type of injury or problem that prevents them from participating in physical activities.</inclusion_criteria>
      <agemin>20 years</agemin>
      <agemax>27 years</agemax>
      <gender>Female</gender>
      <exclusion_criteria></exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code></hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword></hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Other</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: green coffee and green tea approved by the Food and Drug Organization will be purchased from a reputable store with a special grinder, the experimental groups will receive the amount of green coffee equal to 3 mg per kilogram of body weight and the amount of green tea equal to 3 mg per kilogram of body weight. The body will receive 250 ml of boiling water in separate containers every day 20 minutes before breakfast and 20 minutes before lunch at the same time. After finishing the last session in all groups, the second blood sampling was done before breakfast. Also, the physical and physiological indicators of the subjects will be measured. To implement the progressive aerobic exercise program, the subjects of the experimental and control groups in an eight-week aerobic exercise program, three sessions a week, each session 60 minutes with an intensity of 65 to 85% of the maximum heart rate according to table (1) after measurement Anthropometric characteristics will be included. The program of one session included 10 minutes of warm-up, 30 minutes of aerobic exercise (aerobic) running and local movements, and 5 minutes of cooling down, which started with an intensity of 65% of the maximum heart rate and 5% every two weeks. In the last week, reach 85% of the maximum heart rate</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Fat oxidation and blood pressure. Timepoint: After grouping the subjects, the first blood draw will be done (one day before training, consumption of green coffee/green tea). At the beginning of the session, the height of the subjects will be measured using a Seka stadiometer, made in Germany, without shoes. Weight measurement will be done without shoes and with a Seka digital scale made in Germany. Then, the body composition of the people was calculated using the body analysis device of Javon model made in South Korea. One day after taking blood in the first stage and measuring the physical and physiological indicators in all four groups, the subjects will participate in progressive aerobic exercises for three days a week for eight weeks. The experimental groups will receive green tea or green coffee or both depending on the experimental group for eight weeks. Method of measurement: At the beginning of the session, the height of the subjects will be measured using a Seka stadiometer, made in Germany, without shoes. Weight measurement will be done without shoes and with a Seka digital scale made in Germany. Then, the body composition of the people will be calculated using the body analysis device Javon model made in South Korea. Green coffee and green tea approved by the Food and Drug Organization will be purchased from a reputable store with a special powder grinder, every day 20 minutes before breakfast and 20 Minutes before lunch at the same time, they will receive tea. After finishing the last session in all groups, the second blood sampling will be done before breakfast. Also, the physical and physiological indicators of the subjects will be measured.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Islamic Azad University</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2022-09-26</approval_date>
        <contact_name>Ethics committee of Kermanshah University of Medical Sciences</contact_name>
        <contact_address>Shahid Beheshti Blvd., Building No. 2 of Medical Sciences, Research and Technology Vice-Chancellor Kermanshah Kermanshah Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
